• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Total number of electronic OWH distributions in English and other foreign languages in the quarter

Dictionary: A key focus of OWH outreach is being responsive to and anticipating the informational needs created by the diversity of women within the community we serve. Developing and disseminating health information related to FDA regulated products in English, Spanish and a number of other foreign languages provides equity of access. In addition, we actively cultivate organizations wishing to use our translations to reach their own non-English speaking audiences. Measuring the number of documents distributed through our various partnership and other mechanisms allows us to access minority and underserved populations, monitor output, and need/interest areas. In an effort to reach consumers in social media/online space, OWH utilizes online technologies such as Twitter (http://www.twitter.com/fdawomen), e-blasts, and multi-level media (videos, PSA's ,etc) to reach the public with real time, need-to-know women's health information, FDA approvals, recalls and alerts.

Fiscal Year - 2013

Skip graphic and jump to text data

TimeTargetNumber of Distributions
Oct-Dec 2012N/A99,703
Jan–Mar 2013N/A117,661
Apr–Jun 2013N/A128,904
Jul-Sept 2013N/A77,076

FY 2013 Total: 423,344

Number of OWH FDA website downloads

Fiscal Year - 2013
Skip graphic and jump to text data.

TimeTargetNumber of Downloads
Oct 2012N/A32,430
Nov 2012N/A32,169
Dec 2012N/A35,104
Jan 2013N/A43,708
Feb 2013N/A42,429
Mar 2013N/A31,524
Apr 2013N/A32,705
May 2013N/A62,510
Jun 2013N/A33,689
Jul 2013N/A28,297
Aug 2013N/A24,507
Sep 2013N/A24,272

FY 2013 Total: 423,344


Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.